https://wikimd.org/index.php?action=history&feed=atom&title=Fadrozole 2026-04-25T23:11:55Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Fadrozole&diff=5809191&oldid=prev 2024-05-22T17:44:18Z

<p>CSV import</p> <p><b>New page</b></p><div>[[File:Fadrozole_structure.svg|thumb|Fadrozole_structure.svg]] &#039;&#039;&#039;Fadrozole&#039;&#039;&#039; is a nonsteroidal [[aromatase inhibitor]] that is primarily used in the treatment of [[estrogen receptor-positive breast cancer]]. It works by inhibiting the enzyme [[aromatase]], which is responsible for the conversion of [[androgens]] to [[estrogens]]. This reduction in estrogen levels can help slow the growth of certain types of breast cancer that require estrogen to grow.<br /> <br /> ==Mechanism of Action==<br /> Fadrozole inhibits the [[aromatase]] enzyme, which is a key enzyme in the biosynthesis of [[estrogens]]. By blocking this enzyme, fadrozole reduces the production of [[estrogens]] from [[androgens]] in peripheral tissues. This leads to a decrease in circulating estrogen levels, which can help in the management of estrogen-dependent conditions such as [[breast cancer]].<br /> <br /> ==Clinical Uses==<br /> Fadrozole is primarily used in the treatment of [[estrogen receptor-positive breast cancer]] in postmenopausal women. It may also be used in other conditions where estrogen suppression is beneficial, although its use is less common compared to other [[aromatase inhibitors]] like [[anastrozole]] and [[letrozole]].<br /> <br /> ==Side Effects==<br /> Common side effects of fadrozole include:<br /> * [[Hot flashes]]<br /> * [[Nausea]]<br /> * [[Fatigue]]<br /> * [[Headache]]<br /> * [[Joint pain]]<br /> <br /> Less common but more serious side effects can include:<br /> * [[Osteoporosis]]<br /> * [[Cardiovascular events]]<br /> * [[Liver dysfunction]]<br /> <br /> ==Pharmacokinetics==<br /> Fadrozole is administered orally and is well-absorbed from the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily in the urine. The half-life of fadrozole allows for once-daily dosing.<br /> <br /> ==Comparison with Other Aromatase Inhibitors==<br /> Fadrozole is one of several [[aromatase inhibitors]] used in the treatment of [[breast cancer]]. Other commonly used [[aromatase inhibitors]] include [[anastrozole]], [[letrozole]], and [[exemestane]]. Each of these drugs has a slightly different mechanism of action and side effect profile, but all work to reduce estrogen levels in the body.<br /> <br /> ==Research and Development==<br /> Research is ongoing to better understand the full potential of fadrozole in various estrogen-dependent conditions. Studies are also being conducted to compare its efficacy and safety profile with other [[aromatase inhibitors]].<br /> <br /> ==See Also==<br /> * [[Aromatase]]<br /> * [[Breast cancer]]<br /> * [[Anastrozole]]<br /> * [[Letrozole]]<br /> * [[Exemestane]]<br /> <br /> ==References==<br /> {{Reflist}}<br /> <br /> ==External Links==<br /> {{No external links}}<br /> <br /> [[Category:Aromatase inhibitors]]<br /> [[Category:Breast cancer]]<br /> [[Category:Hormonal antineoplastic drugs]]<br /> [[Category:Nonsteroidal antiandrogens]]<br /> <br /> {{medicine-stub}}</div>

Prab